Academic Journal
Impact of Model for End-Stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates.
| Title: | Impact of Model for End-Stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates. |
|---|---|
| Authors: | Lim WH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: whlim0403@gmail.com., Tan DJH; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Mitra K; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Teng MLP; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore., Ng CH; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; Department of Digestive Disease Information and Research, School of Medicine, Kurume University, Fukuoka, Japan., Ko D; Department of Medicine, Bridgeport Hospital Yale New Haven Health, Bridgeport, Connecticut., Syn N; Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Kow AW; Division of Hepatopancreaticobiliary Surgery and Liver Transplantation, Department of Surgery, National University Health System Singapore, Singapore., Tung D; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore., Nakajima A; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan., Sumida Y; Department of Internal Medicine, Division of Hepatology and Pancreatology, Aichi Medical University, Aichi, Japan; Department of Healthcare Management, International University of Health and Welfare, Tokyo, Japan., Takahashi H; Liver Center, Saga University Hospital, Saga, Japan., Tan EXX; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; National University Centre for Organ Transplantation, National University Health System, Singapore., Noureddin M; Houston Methodist Hospital and Houston Research Institute, Houston, Texas., Chen VL; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan., Wijarnpreecha K; Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine, Phoenix, Arizona; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, Arizona; BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona., Huang DQ; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore., Bui AT; Department of Statistical Sciences and Operations Research, Virginia Commonwealth University (VCU), Richmond, Virginia., Muthiah M; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore., Siddiqui MS; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, Virginia; Hume-Lee Transplant Center, Virginia Commonwealth University Health System, Richmond, Virginia. Electronic address: mohammad.siddiqui@vcuhealth.org. |
| Source: | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2026 Aug; Vol. 24 (8), pp. 2181-2190. Date of Electronic Publication: 2025 Oct 25. |
| Publication Type: | Journal Article |
| Language: | English |
| Journal Info: | Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-7714 (Electronic) Linking ISSN: 15423565 NLM ISO Abbreviation: Clin Gastroenterol Hepatol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Philadelphia, PA : W.B. Saunders for the American Gastroenterological Association, 2003- |
| MeSH Terms: | Waiting Lists*/mortality , Liver Transplantation*/statistics & numerical data , Liver Cirrhosis*/surgery , Liver Cirrhosis*/mortality , End Stage Liver Disease*/surgery , End Stage Liver Disease*/mortality , Fatty Liver*/complications, Humans ; Female ; Retrospective Studies ; Middle Aged ; Male ; Adult ; Severity of Illness Index ; Aged ; Registries |
| Abstract: | Background & Aims: Metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis is rapidly growing as an indication for liver transplantation (LT). However, the impact of Model for End-stage Liver Disease (MELD) 3.0 on waitlist outcomes in this population is not established. This study assessed the impact of MELD 3.0 on waitlist outcomes of patients with MASH cirrhosis using the Scientific Registry of Transplant Recipients database. Methods: This was a retrospective analysis of the Scientific Registry of Transplant Recipients/United Network for Organ Sharing database including LT waitlist registrants from January 1, 2016, to December 31, 2022. Primary outcomes were 90-day waitlist mortality and transplantation probability in patients with MASH vs non-MASH cirrhosis. Results: Among 44,037 waitlist registrants, 12,790 had MASH cirrhosis and 31,247 had non-MASH cirrhosis. The median follow-up was 2.63 months. In MASH cirrhosis, 65.4% were up-categorized and 11.2% were down-categorized when transitioning from MELD-Na to MELD 3.0. Up-categorization was associated with higher 90-day waitlist mortality (hazard ratio, 1.14; 95% confidence interval, 1.05-1.24; P = .002) but not higher transplantation probability (hazard ratio, 1.04; 95% confidence interval, 0.98-1.09; P = .18). Among female patients with MASH cirrhosis, up-categorization similarly did not translate into improved transplant probability. Conclusions: Although MELD 3.0 reclassifies a substantial proportion of patients with MASH-particularly women-it does not appear to increase transplant access despite higher predicted mortality risk. These findings highlight residual gaps in how MELD 3.0 captures clinical risk in MASH cirrhosis and underscore the need for prospective data following its implementation. (Copyright © 2025 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights reserved.) |
| Contributed Indexing: | Keywords: Cirrhosis; Liver Transplantation; Model for End-Stage Liver Disease (MELD) Score; Nonalcoholic Steatohepatitis; Waitlist Mortality |
| Entry Date(s): | Date Created: 20251124 Date Completed: 20260722 Latest Revision: 20260722 |
| Update Code: | 20260723 |
| DOI: | 10.1016/j.cgh.2025.10.016 |
| PMID: | 41284513 |
| Database: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://www.doi.org/10.1016/j.cgh.2025.10.016? Name: ScienceDirect (all content) (s7799221) Category: fullText Text: View record from ScienceDirect MouseOverText: View record from ScienceDirect – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=15427714&ISBN=&volume=24&issue=8&date=20260801&spage=2181&pages=2181-2190&title=Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association&atitle=Impact%20of%20Model%20for%20End-Stage%20Liver%20Disease%203.0%20on%20Waitlist%20Outcomes%20of%20Metabolic%20Dysfunction-Associated%20Steatohepatitis%20Cirrhosis%20Among%20Liver%20Transplant%20Candidates.&aulast=Lim%20WH&id=DOI:10.1016/j.cgh.2025.10.016 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 41284513 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Impact of Model for End-Stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lim+WH%22">Lim WH</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: whlim0403@gmail.com.<br /><searchLink fieldCode="AU" term="%22Tan+DJH%22">Tan DJH</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Mitra+K%22">Mitra K</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Teng+MLP%22">Teng MLP</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ng+CH%22">Ng CH</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; Department of Digestive Disease Information and Research, School of Medicine, Kurume University, Fukuoka, Japan.<br /><searchLink fieldCode="AU" term="%22Ko+D%22">Ko D</searchLink>; Department of Medicine, Bridgeport Hospital Yale New Haven Health, Bridgeport, Connecticut.<br /><searchLink fieldCode="AU" term="%22Syn+N%22">Syn N</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Kow+AW%22">Kow AW</searchLink>; Division of Hepatopancreaticobiliary Surgery and Liver Transplantation, Department of Surgery, National University Health System Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tung+D%22">Tung D</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Nakajima+A%22">Nakajima A</searchLink>; Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Sumida+Y%22">Sumida Y</searchLink>; Department of Internal Medicine, Division of Hepatology and Pancreatology, Aichi Medical University, Aichi, Japan; Department of Healthcare Management, International University of Health and Welfare, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Takahashi+H%22">Takahashi H</searchLink>; Liver Center, Saga University Hospital, Saga, Japan.<br /><searchLink fieldCode="AU" term="%22Tan+EXX%22">Tan EXX</searchLink>; Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; National University Centre for Organ Transplantation, National University Health System, Singapore.<br /><searchLink fieldCode="AU" term="%22Noureddin+M%22">Noureddin M</searchLink>; Houston Methodist Hospital and Houston Research Institute, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Chen+VL%22">Chen VL</searchLink>; Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Wijarnpreecha+K%22">Wijarnpreecha K</searchLink>; Department of Medicine, Division of Gastroenterology and Hepatology, University of Arizona College of Medicine, Phoenix, Arizona; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Banner University Medical Center, Phoenix, Arizona; BIO5 Institute, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona.<br /><searchLink fieldCode="AU" term="%22Huang+DQ%22">Huang DQ</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Bui+AT%22">Bui AT</searchLink>; Department of Statistical Sciences and Operations Research, Virginia Commonwealth University (VCU), Richmond, Virginia.<br /><searchLink fieldCode="AU" term="%22Muthiah+M%22">Muthiah M</searchLink>; Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, Singapore, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; National University Centre for Organ Transplantation, National University Health System, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Siddiqui+MS%22">Siddiqui MS</searchLink>; Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University Health System, Richmond, Virginia; Hume-Lee Transplant Center, Virginia Commonwealth University Health System, Richmond, Virginia. Electronic address: mohammad.siddiqui@vcuhealth.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101160775%22">Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association</searchLink> [Clin Gastroenterol Hepatol] 2026 Aug; Vol. 24 (8), pp. 2181-2190. <i>Date of Electronic Publication: </i>2025 Oct 25. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22W%2EB%2E+Saunders+for+the+American+Gastroenterological+Association%22">W.B. Saunders for the American Gastroenterological Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101160775 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1542-7714 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215423565%22">15423565 </searchLink><i>NLM ISO Abbreviation: </i>Clin Gastroenterol Hepatol <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Original Publication</i>: Philadelphia, PA : W.B. Saunders for the American Gastroenterological Association, 2003- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Waiting+Lists%22">Waiting Lists*</searchLink>/<searchLink fieldCode="MM" term="%22Waiting+Lists+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22Liver+Transplantation%22">Liver Transplantation*</searchLink>/<searchLink fieldCode="MM" term="%22Liver+Transplantation+statistics+%26+numerical+data%22">statistics & numerical data</searchLink> <br /><searchLink fieldCode="MM" term="%22Liver+Cirrhosis%22">Liver Cirrhosis*</searchLink>/<searchLink fieldCode="MM" term="%22Liver+Cirrhosis+surgery%22">surgery</searchLink> <br /><searchLink fieldCode="MM" term="%22Liver+Cirrhosis%22">Liver Cirrhosis*</searchLink>/<searchLink fieldCode="MM" term="%22Liver+Cirrhosis+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22End+Stage+Liver+Disease%22">End Stage Liver Disease*</searchLink>/<searchLink fieldCode="MM" term="%22End+Stage+Liver+Disease+surgery%22">surgery</searchLink> <br /><searchLink fieldCode="MM" term="%22End+Stage+Liver+Disease%22">End Stage Liver Disease*</searchLink>/<searchLink fieldCode="MM" term="%22End+Stage+Liver+Disease+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22Fatty+Liver%22">Fatty Liver*</searchLink>/<searchLink fieldCode="MM" term="%22Fatty+Liver+complications%22">complications</searchLink><br /><searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Retrospective+Studies%22">Retrospective Studies</searchLink> ; <searchLink fieldCode="MH" term="%22Middle+Aged%22">Middle Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Adult%22">Adult</searchLink> ; <searchLink fieldCode="MH" term="%22Severity+of+Illness+Index%22">Severity of Illness Index</searchLink> ; <searchLink fieldCode="MH" term="%22Aged%22">Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Registries%22">Registries</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background & Aims: Metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis is rapidly growing as an indication for liver transplantation (LT). However, the impact of Model for End-stage Liver Disease (MELD) 3.0 on waitlist outcomes in this population is not established. This study assessed the impact of MELD 3.0 on waitlist outcomes of patients with MASH cirrhosis using the Scientific Registry of Transplant Recipients database.<br />Methods: This was a retrospective analysis of the Scientific Registry of Transplant Recipients/United Network for Organ Sharing database including LT waitlist registrants from January 1, 2016, to December 31, 2022. Primary outcomes were 90-day waitlist mortality and transplantation probability in patients with MASH vs non-MASH cirrhosis.<br />Results: Among 44,037 waitlist registrants, 12,790 had MASH cirrhosis and 31,247 had non-MASH cirrhosis. The median follow-up was 2.63 months. In MASH cirrhosis, 65.4% were up-categorized and 11.2% were down-categorized when transitioning from MELD-Na to MELD 3.0. Up-categorization was associated with higher 90-day waitlist mortality (hazard ratio, 1.14; 95% confidence interval, 1.05-1.24; P = .002) but not higher transplantation probability (hazard ratio, 1.04; 95% confidence interval, 0.98-1.09; P = .18). Among female patients with MASH cirrhosis, up-categorization similarly did not translate into improved transplant probability.<br />Conclusions: Although MELD 3.0 reclassifies a substantial proportion of patients with MASH-particularly women-it does not appear to increase transplant access despite higher predicted mortality risk. These findings highlight residual gaps in how MELD 3.0 captures clinical risk in MASH cirrhosis and underscore the need for prospective data following its implementation.<br /> (Copyright © 2025 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights reserved.) – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Cirrhosis; Liver Transplantation; Model for End-Stage Liver Disease (MELD) Score; Nonalcoholic Steatohepatitis; Waitlist Mortality – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20251124 <i>Date Completed: </i>20260722 <i>Latest Revision: </i>20260722 – Name: DateUpdate Label: Update Code Group: Date Data: 20260723 – Name: DOI Label: DOI Group: ID Data: 10.1016/j.cgh.2025.10.016 – Name: AN Label: PMID Group: ID Data: 41284513 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=41284513 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cgh.2025.10.016 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2181 Subjects: – SubjectFull: Humans Type: general – SubjectFull: Female Type: general – SubjectFull: Retrospective Studies Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: Male Type: general – SubjectFull: Adult Type: general – SubjectFull: Severity of Illness Index Type: general – SubjectFull: Aged Type: general – SubjectFull: Registries Type: general – SubjectFull: Waiting Lists mortality Type: general – SubjectFull: Liver Transplantation statistics & numerical data Type: general – SubjectFull: Liver Cirrhosis surgery Type: general – SubjectFull: Liver Cirrhosis mortality Type: general – SubjectFull: End Stage Liver Disease surgery Type: general – SubjectFull: End Stage Liver Disease mortality Type: general – SubjectFull: Fatty Liver complications Type: general Titles: – TitleFull: Impact of Model for End-Stage Liver Disease 3.0 on Waitlist Outcomes of Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis Among Liver Transplant Candidates. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lim WH – PersonEntity: Name: NameFull: Tan DJH – PersonEntity: Name: NameFull: Mitra K – PersonEntity: Name: NameFull: Teng MLP – PersonEntity: Name: NameFull: Ng CH – PersonEntity: Name: NameFull: Ko D – PersonEntity: Name: NameFull: Syn N – PersonEntity: Name: NameFull: Kow AW – PersonEntity: Name: NameFull: Tung D – PersonEntity: Name: NameFull: Nakajima A – PersonEntity: Name: NameFull: Sumida Y – PersonEntity: Name: NameFull: Takahashi H – PersonEntity: Name: NameFull: Tan EXX – PersonEntity: Name: NameFull: Noureddin M – PersonEntity: Name: NameFull: Chen VL – PersonEntity: Name: NameFull: Wijarnpreecha K – PersonEntity: Name: NameFull: Huang DQ – PersonEntity: Name: NameFull: Bui AT – PersonEntity: Name: NameFull: Muthiah M – PersonEntity: Name: NameFull: Siddiqui MS IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2026 Aug Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1542-7714 Numbering: – Type: volume Value: 24 – Type: issue Value: 8 Titles: – TitleFull: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association Type: main |
| ResultId | 1 |